Director James N. Wilson's Gift of 5,000 Corcept Therapeutics Shares

This SEC Form 4 filing reports that James N. Wilson, a director of Corcept Therapeutics Inc., gifted 5,000 shares of common stock on April 6, 2026. The transaction was coded as a gift (transaction code G) with a price per share of $0.00. Following this transaction, Wilson's total direct and indirect holdings in Corcept Therapeutics amount to 1,097,532 shares. The filing includes detailed ownership information showing Wilson's indirect holdings through various family trusts and partnerships, including 901,067 shares held by James and Pamela Wilson Family Partners, and 200,000 shares each held by two separate Grantor Retained Annuity Trusts established in 2025. The filing notes that Wilson has voting power over shares held by the family trusts and partnerships but disclaims beneficial ownership except to the extent of his pecuniary interest.